Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x)

Reshani H. Perera; Luis Solorio; Hanping Wu; Mihika Gangolli; Eric Silverman; Christopher Hernandez; Pubudu M. Peiris; Ann Marie Broome; Agata A. Exner

doi:10.1007/s11095-014-1327-1

Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x)

Reshani H. Perera, Luis Solorio, Hanping Wu, Mihika Gangolli, Eric Silverman, Christopher Hernandez, Pubudu M. Peiris, Ann Marie Broome, Agata A. Exner

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1877
Number of pages	1
Journal	Pharmaceutical Research
Volume	31
Issue number	7
DOIs	https://doi.org/10.1007/s11095-014-1327-1
State	Published - Jul 2014
Externally published	Yes

ASJC Scopus subject areas

Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Organic Chemistry
Pharmacology (medical)

Access to Document

10.1007/s11095-014-1327-1

Cite this

Perera, R. H., Solorio, L., Wu, H., Gangolli, M., Silverman, E., Hernandez, C., Peiris, P. M., Broome, A. M., & Exner, A. A. (2014). Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x). Pharmaceutical Research, 31(7), 1877. https://doi.org/10.1007/s11095-014-1327-1

Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x). / Perera, Reshani H.; Solorio, Luis; Wu, Hanping et al.
In: Pharmaceutical Research, Vol. 31, No. 7, 07.2014, p. 1877.

Research output: Contribution to journal › Comment/debate › peer-review

Perera, RH, Solorio, L, Wu, H, Gangolli, M, Silverman, E, Hernandez, C, Peiris, PM, Broome, AM & Exner, AA 2014, 'Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x)', Pharmaceutical Research, vol. 31, no. 7, pp. 1877. https://doi.org/10.1007/s11095-014-1327-1

@article{a3dd112b9015421a96cccfb45112b95c,

title = "Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x)",

author = "Perera, {Reshani H.} and Luis Solorio and Hanping Wu and Mihika Gangolli and Eric Silverman and Christopher Hernandez and Peiris, {Pubudu M.} and Broome, {Ann Marie} and Exner, {Agata A.}",

year = "2014",

month = jul,

doi = "10.1007/s11095-014-1327-1",

language = "English (US)",

volume = "31",

pages = "1877",

journal = "Pharmaceutical Research",

issn = "0724-8741",

publisher = "Springer New York",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x)

AU - Perera, Reshani H.

AU - Solorio, Luis

AU - Wu, Hanping

AU - Gangolli, Mihika

AU - Silverman, Eric

AU - Hernandez, Christopher

AU - Peiris, Pubudu M.

AU - Broome, Ann Marie

AU - Exner, Agata A.

PY - 2014/7

Y1 - 2014/7

UR - http://www.scopus.com/inward/record.url?scp=84904252687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904252687&partnerID=8YFLogxK

U2 - 10.1007/s11095-014-1327-1

DO - 10.1007/s11095-014-1327-1

M3 - Comment/debate

AN - SCOPUS:84904252687

SN - 0724-8741

VL - 31

SP - 1877

JO - Pharmaceutical Research

JF - Pharmaceutical Research

IS - 7

ER -

Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this